H. Lundbeck A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA)
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 360
- Registration Number
- NCT06706622
- Locations
- 🇺🇸
CenExel Rocky Mountain Clinical Research, LLC, Englewood, Colorado, United States
🇺🇸QUEST Research Institute, Farmington Hills, Michigan, United States
🇺🇸Inland Northwest Research, Spokane, Washington, United States
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 150
- Registration Number
- NCT06701526
- Locations
- 🇺🇸
Neuroscience Research Center, LLC, Canton, Ohio, United States
A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 40
- Registration Number
- NCT06578585
- Locations
- 🇺🇸
Clinical Neuroscience Solutions, Orlando, Florida, United States
🇺🇸NeuroTrials Research, Atlanta, Georgia, United States
🇺🇸Future Search Trials, Austin, Texas, United States
A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 19
- Registration Number
- NCT06557850
- Locations
- 🇧🇦
University Clinical Center of The Republic Of Srpska, Banja Luka, Republika Srpska, Bosnia and Herzegovina
🇵🇱Uniewrsyteckie Centru Kliniczne, Katowice, Poland
🇧🇬Diagnostic-Consultative Center Alexandrovska, Sofia, Bulgaria
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 18
- Registration Number
- NCT06471829
- Locations
- 🇬🇪
National Institute of Endocrinology, Tbilisi, Georgia
🇬🇪Tbilisi Central Hospital, Tbilisi, Georgia
🇬🇪Multiprofile Clinic Consilium Medulla, Tbilisi, Georgia
A Study Investigating the Movement of Lu AF28996 Into, Through, and Out of the Body of Healthy Men
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 8
- Registration Number
- NCT06337110
- Locations
- 🇬🇧
Fortrea Clinical Research Unit Ltd, Leeds, United Kingdom
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 498
- Registration Number
- NCT06323928
- Locations
- 🇯🇵
Ikeda Neurosurgery Clinic, Kasuga-shi, Fukuoka-Ken, Japan
🇯🇵Nakamura Memorial Hospital, Sapporo, Hokkaid¿, Japan
🇯🇵Mito Kyodo General Hospital, Mito, Ibaraki, Japan
A Trial Investigating Lu AF28996 in Healthy Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 22
- Registration Number
- NCT06277609
- Locations
- 🇺🇸
Covance Dallas CRU, Dallas, Texas, United States
A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT06258720
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, China
A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants
- Conditions
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 26
- Registration Number
- NCT06077786
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands